BlackRock’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,749,863
Closed -$323M 5876
2022
Q3
$323M Sell
4,749,863
-22,528
-0.5% -$1.53M 0.01% 1111
2022
Q2
$152M Sell
4,772,391
-512,120
-10% -$16.4M ﹤0.01% 1716
2022
Q1
$183M Sell
5,284,511
-68,545
-1% -$2.37M ﹤0.01% 1722
2021
Q4
$157M Sell
5,353,056
-418,159
-7% -$12.2M ﹤0.01% 1900
2021
Q3
$147M Buy
5,771,215
+983
+0% +$25K ﹤0.01% 1928
2021
Q2
$202M Buy
5,770,232
+1,578,003
+38% +$55.3M 0.01% 1744
2021
Q1
$171M Buy
4,192,229
+508,969
+14% +$20.7M 0.01% 1824
2020
Q4
$160M Buy
3,683,260
+367,275
+11% +$15.9M 0.01% 1766
2020
Q3
$183M Sell
3,315,985
-284,050
-8% -$15.7M 0.01% 1443
2020
Q2
$227M Sell
3,600,035
-1,176,885
-25% -$74.3M 0.01% 1265
2020
Q1
$244M Sell
4,776,920
-78,253
-2% -$4M 0.01% 1014
2019
Q4
$386M Sell
4,855,173
-113,670
-2% -$9.04M 0.01% 995
2019
Q3
$241M Buy
4,968,843
+486,115
+11% +$23.6M 0.01% 1265
2019
Q2
$236M Buy
4,482,728
+205,785
+5% +$10.8M 0.01% 1299
2019
Q1
$226M Buy
4,276,943
+50,598
+1% +$2.68M 0.01% 1324
2018
Q4
$173M Buy
4,226,345
+40,076
+1% +$1.65M 0.01% 1414
2018
Q3
$159M Buy
4,186,269
+43,507
+1% +$1.65M 0.01% 1637
2018
Q2
$187M Buy
4,142,762
+898,162
+28% +$40.6M 0.01% 1502
2018
Q1
$157M Sell
3,244,600
-75,282
-2% -$3.64M 0.01% 1534
2017
Q4
$131M Sell
3,319,882
-207,426
-6% -$8.16M 0.01% 1670
2017
Q3
$110M Buy
3,527,308
+122,770
+4% +$3.81M 0.01% 1794
2017
Q2
$93.1M Buy
3,404,538
+785,691
+30% +$21.5M ﹤0.01% 1840
2017
Q1
$96.5M Buy
2,618,847
+2,564,008
+4,676% +$94.5M 0.01% 1796
2016
Q4
$792K Buy
54,839
+5,100
+10% +$73.7K ﹤0.01% 1545
2016
Q3
$1.15M Buy
49,739
+775
+2% +$17.9K ﹤0.01% 1399
2016
Q2
$812K Buy
48,964
+48,579
+12,618% +$806K ﹤0.01% 1480
2016
Q1
$6K Sell
385
-515
-57% -$8.03K ﹤0.01% 3294
2015
Q4
$29K Sell
900
-30,800
-97% -$992K ﹤0.01% 2353
2015
Q3
$1.34M Buy
+31,700
New +$1.34M ﹤0.01% 1168